Skip to content

Private health insurers do not want to pay for Lauterbach's hospital reform

Despite the call from the traffic light coalition, private health insurance (PKV) is refusing to participate in the costs of Health Minister Karl Lauterbach's (SPD) hospital reform. Association director Florian Reuther told "Redaktionsnetzwerk Deutschland" (Thursday editions) that the financing of the transformation fund planned for the restructuring of the hospital landscape at the expense of the premium payers of statutory and private health insurance "we consider [...] PKV does not want to pay for Lauterbach's hospital reform

Complete blood count detects cancer

The complete blood count is a comprehensive examination of the blood that can provide important information about the state of health, including possible indications of cancer. It includes the analysis of various blood components and can reveal deviations from normal values that could indicate cancer. A central component of the complete blood count is the determination of leukocytes (white blood cells). The normal value is between 4,000 and 10,000 per microliter of blood[1]. A significant increase in the leukocyte count (leukocytosis) can indicate various diseases, including leukemia. In acute leukemia, the values can rise to over 100,000 per microliter. However, leukocytosis alone is not a definitive cancer diagnosis, as it can also occur with infections[1]. Erythrocytes (red blood cells) are also examined in the complete blood count. Normal values for women are between 4.1 and 5.1 million per microliter and for men between 4.5 and 5.9 million per microliter[1]. A decrease in...

Multiple Sclerosis (MS) Therapy: Enormous Progress in Treatment

  • News

In recent years, significant therapeutic advances have been made in the treatment of multiple sclerosis (MS). New active substances and therapeutic approaches promise improved control of disease activity and slowing of disability progression. An important milestone was the introduction of B-cell-depleting antibodies such as Ocrelizumab (Ocrevus). Long-term data over 9 years now show the benefits of early treatment: 48.2% of patients who received Ocrelizumab from the start showed no disease activity, compared to only 25.7% with a later switch from interferon[1]. This underscores the importance of early initiation of treatment with highly effective medications. Bruton's tyrosine kinase inhibitors (BTKIs), a new class of drugs currently being investigated in Phase 3 studies, are also promising. Substances such as Evobrutinib, Tolebrutinib, and Fenebrutinib, unlike antibodies, can cross the blood-brain barrier and are intended to suppress smoldering CNS inflammation[5]. However, Evobrutinib missed the primary endpoint of reducing relapse rate compared to Teriflunomide in two Phase 3 studies[6]. This raises the question… 

AI can also be a risk for medicine

  • News

Artificial intelligence (AI) has enabled enormous advances in medicine in recent years, but it also carries significant risks that must be carefully weighed. A central problem is data security and the protection of patient privacy. Medical data is extremely sensitive and valuable, which is why it is often the target of cyberattacks[1]. The extensive central storage and analysis of health data by AI systems further increases this risk[2]. Another serious risk is possible misdiagnoses and treatment errors by AI systems. While large language-based AI models can generate seemingly professional answers, these can contain serious errors, especially when it comes to medical questions[3]. A concrete example would be an AI system that incorrectly classifies skin changes as harmless, while a dermatologist would recognize them as potentially cancerous[2]. The World Health Organization (WHO) also warns of the risk that AI technology could be misused to spread misinformation, which...

Generative AI in Clinical Research

Generative AI is increasingly revolutionizing clinical research, promising to make many processes more efficient and effective. A key area of application is accelerating patient recruitment for clinical trials. Researchers at Mass General Brigham Hospital have shown that AI software like ChatGPT can significantly speed up the screening process for identifying suitable study participants[8]. In their study, they used a version of OpenAI's GPT-4 via Microsoft's Azure cloud to search patient records for eligibility criteria for a heart failure study. The AI achieved an accuracy of 97.9% to 100% compared to expert assessment – at a cost of only 11 cents per patient on average[8]. Generative AI is also used in the creation of study protocols and the analysis of study data. The company Intelligent Medical Objects has developed a method called SEETrials to extract safety and efficacy information from study abstracts using GPT-4[9]. This allows researchers to get a quick overview... 

Healthcare: Cyberattacks Threaten Patients' Lives

More and more healthcare organizations are falling victim to cyberattacks, and the incidents are negatively impacting patient care. This is according to a survey by cybersecurity company Proofpoint and research firm Ponemon Institute. The report found that 92 percent of healthcare organizations experienced at least one cyberattack in the past twelve months, up from 88 percent last year. Nearly 70 percent said the attacks impacted patient care. 56 percent of organizations that faced the four common types of cyberattacks reported poor patient outcomes due to treatment delays, 53 percent said there were more complications during procedures, and 28 percent said patient mortality rates increased. https://www.proofpoint.com/us/resources/threat-reports/ponemon-healthcare-cybersecurity-report

FDZ to revolutionize medical research

The Research Data Center (FDZ) Health is about to open and promises to revolutionize medical research in Germany. With access to the billing data of 73 million statutory insured persons, the FDZ offers a unique data source for scientists and researchers[1]. Rebecca Alvarado, a representative of the FDZ, explains using the example of Long Covid how this data could be used. It could help answer questions about pre-existing conditions, particularly affected groups, and effective treatment methods[1]. Access to this valuable data is carefully controlled. Interested parties must submit a detailed application outlining their research goals. Upon approval, they will gain access to a virtual analysis environment, with the data itself remaining within the system. This ensures both the security and usability of the information[1]. Starting in summer 2025, anonymized data from electronic health records will also be integrated into the FDZ, beginning with the medication plan. It is important that the… 

Disaster control: Hurricanes can hit Germany

There are currently three active hurricanes in the Atlantic, one of which will reach us as a storm depression this Thursday. At the same time, the particularly strong hurricane Milton is making landfall on Florida's coast. What do these hurricanes mean for the affected areas, how does this affect Germany, and can hurricanes even reach Europe if they are still active? 3 questions from Johanna Lindner to Andreas Machalica, meteorologist at wetter.com. How does MILTON differ from other hurricanes, what makes it so particularly dangerous? The special thing is that it developed extremely rapidly at the beginning of this week – as rapidly as a hurricane rarely has before. On Monday, it intensified to Category 5 within 11 hours, which is one of the fastest intensifications since weather records began. The extremely high water temperatures in the Gulf of Mexico are responsible for this. We currently have about 1… 

Germany: 20,000 deaths annually due to medical treatment errors

Medical treatment errors lead to a considerable number of deaths in Germany every year, although the exact figures are disputed and vary depending on the source. According to the current statistics from the Medical Service of the Health Insurance Funds (MD) for 2023, 75 patients demonstrably died due to treatment errors[1][2]. This figure is based on 12,438 reviewed cases where patients had expressed suspicion of a treatment error[1]. However, experts assume a significantly higher number of unreported cases. Stefan Gronemeyer, Chairman of the MD, refers to estimates suggesting that around 17,000 error-related, preventable deaths could occur annually in German hospitals[1][2]. This assessment is based, among other things, on a study by the Action Alliance Patient Safety[1]. The AOK hospital report provides even more alarming figures. According to this, up to 19,000 patients could die each year due to treatment errors[6]. The report estimates that serious incidents occur in around 190,000 cases, of which about 10 percent are fatal[6]. The discrepancy… 

Hospital: Shortage of skilled workers causes higher infection rates

Insufficient staffing in infection prevention and control is associated with a higher rate of healthcare-associated infections. This is according to a new study published today in the American Journal of Infection Control. The study, conducted by the APIC Center for Research, Practice & Innovation, summarizes a pilot project to evaluate a new online calculator designed to provide facility-specific staffing recommendations for infection prevention. Infection prevention and control programs with staffing levels below expectations had significantly higher rates of central venous catheter-associated bloodstream infections (CLABSI), catheter-associated urinary tract infections (CAUTI), Clostridioides difficile infections, and surgical site infections. For example, 25% of facilities with lower-than-expected staffing had increased CAUTI rates. In comparison, only 7% of hospitals with staffing levels at or above expectations…